topiramate

Poland

Drugs containing this active substance

  • EPITORAM

    The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy in the treatment of epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Lachifarma S.r.L. Laboratory Chemical Pharmaceutical Salentino

  • The medicinal product is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Lachifarma S.r.L. Laboratory Chemical Pharmaceutical Salentino

  • The medicinal product is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Lachifarma S.r.L. Laboratory Chemical Pharmaceutical Salentino

  • Epitoram is an antiepileptic drug. It is used as monotherapy in the treatment of epileptic seizures in adults and children over 6 years of age, as adjunctive therapy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 200 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Lachifarma S.r.L. Laboratory Chemical Pharmaceutical Salentino

  • The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy in the treatment of epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: Bausch Health Poland Sp. z o.o. Bausch Health Poland Sp. z o.o. Pharmathen International S.A. Pharmathen S.A.

  • The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunctive therapy in the treatment of epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: Bausch Health Poland Ltd.

  • The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and also for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 200 mg

    ATC: N03AX11

    Manufacturer: Bausch Health Poland Sp. z o.o. Bausch Health Poland Sp. z o.o. Pharmathen International S.A. Pharmathen S.A.

  • The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy in the treatment of epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: Bausch Health Poland Sp. z o.o. Bausch Health Poland Sp. z o.o. Pharmathen International S.A. Pharmathen S.A.

  • The medicine is used for the treatment of seizures in adults and children (above 6 years of age as monotherapy or above 2 years of age in combination with other medicines). In adults, it is also used for the prevention of migraine attacks.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: Orion Corporation, Orion Pharma

  • Oritop is used to treat seizures in adults and children (over 6 years of age as monotherapy or over 2 years of age in combination with other medicines), and also for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: Orion Corporation, Orion Pharma

  • The medicine is used to treat seizures in adults and children (over 6 years of age as monotherapy or over 2 years of age in combination with other medicines), as well as in adults for the prevention of migraine attacks.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: Orion Corporation, Orion Pharma

  • The medicine is used in adults to help them lose weight and maintain a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or people with overweight (BMI from 27 kg/m²) who have weight-related health problems, such as diabetes, high blood pressure, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

    Form: capsules, hard modified release

    Active substance Dosage
    phentermine hydrochloride 4.67 mg
    topiramate 23 mg

    ATC: A08AA51

    Manufacturer: Catalent Germany Schorndorf GmbH

  • The medicine is used in adults with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) associated with health problems, such as diabetes or high blood pressure. It helps to reduce appetite and supports maintaining a low body weight in combination with diet and physical activity.

    Form: capsules, hard modified release

    Active substance Dosage
    phentermine hydrochloride 9.34 mg
    topiramate 46 mg

    ATC: A08AA51

    Manufacturer: Catalent Germany Schorndorf GmbH

  • Qsiva is used in adults to help them lose weight and maintain a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) who have weight-related health problems, such as diabetes, high blood pressure, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

    Form: capsules, hard modified release

    Active substance Dosage
    phentermine hydrochloride 14 mg
    topiramate 69 mg

    ATC: A08AA51

    Manufacturer: Catalent Germany Schorndorf GmbH

  • The medicine is used in adults to help with weight loss and maintaining a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) who also have a weight-related health problem, such as high blood pressure, diabetes, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

    Form: capsules, hard modified release

    Active substance Dosage
    phentermine hydrochloride 18.66 mg
    topiramate 92 mg

    ATC: A08AA51

    Manufacturer: Catalent Germany Schorndorf GmbH

  • It is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as an adjunctive therapy for epilepsy in children from 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: Janssen Pharmaceutica N.V. Janssen-Cilag S.p.A. Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A.

  • The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: Janssen Pharmaceutica N.V. Janssen-Cilag S.p.A. Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A.

  • The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: Janssen Pharmaceutica N.V. Janssen-Cilag S.p.A. Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A.

  • The medicinal product is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 200 mg

    ATC: N03AX11

    Manufacturer: Janssen Pharmaceutica N.V. Janssen-Cilag S.p.A. Lusomedicamenta - Sociedade Tecnica Farmaceutica S.A.

  • The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as adjunctive therapy for seizures in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: capsules, hard

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: Janssen Cilag S.p.A

  • The medicine is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in children from 2 years of age, and for the prevention of migraine attacks in adults.

    Form: capsules, hard

    Active substance Dosage
    topiramate 15 mg

    ATC: N03AX11

    Manufacturer: Janssen Cilag S.p.A

  • The medicinal product is used as monotherapy for the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in adults and children over 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.

  • It is used to treat seizures in adults and children (above 6 years of age as monotherapy, and from 2 years of age in combination with other medicines). In adults, this medicine is also used for the prevention of migraine attacks.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.

  • It is used in the treatment of epileptic seizures in adults and children (over 6 years of age as monotherapy, and over 2 years of age in combination with other medicines). In adults, this medicine also helps in the prevention of migraine attacks.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.

  • It is used for the treatment of seizures in adults and children (in children over 6 years old as monotherapy, and in children over 2 years old in combination with other medicines) and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 200 mg

    ATC: N03AX11

    Manufacturer: APL Swift Services (Malta) Ltd. Generis Farmacêutica, S.A.

  • The medicine is used as a monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in children from 2 years of age, and in the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 50 mg

    ATC: N03AX11

    Manufacturer: Glenmark Pharmaceuticals s.r.o.

  • The medicine is used as a monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in adults and children from 2 years of age, and in the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 100 mg

    ATC: N03AX11

    Manufacturer: Glenmark Pharmaceuticals s.r.o.

  • The medicine is used as monotherapy in the treatment of seizures in adults and children over 6 years of age, as an adjunct therapy for epilepsy in children from 2 years of age, and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 200 mg

    ATC: N03AX11

    Manufacturer: Glenmark Pharmaceuticals s.r.o.

  • It is used for the treatment of seizures in adults and children (as monotherapy or in combination with other preparations) and for the prevention of migraine attacks in adults.

    Form: tablets, film-coated

    Active substance Dosage
    topiramate 25 mg

    ATC: N03AX11

    Manufacturer: Glenmark Pharmaceuticals s.r.o.